Back

Global Learning Collaborative

  • Dry Eye Syndromes
  • Meibomian Gland Dysfunction
  • Mite Infestations
  • Treatment Delay

At the Lid Line: Unmasking Demodex Across the OSD Spectrum

Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditional therapies and the role of newer, evidence-based options like lotilaner. Enhancing diagnostic accuracy, individualized treatment selection, and implementing structured follow-up can improve adherence and long-term outcomes. Education focused on these strategies aims to reduce misclassification, optimize care, and improve quality of life for patients with DB.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Mar 31, 2026
  • Last day to claim credit
    Aug 1, 2027 10 months left